Insider Selling: Nu Skin Enterprises, Inc. (NYSE:NUS) Director Sells 2,000 Shares of Stock

Nu Skin Enterprises, Inc. (NYSE:NUS - Get Free Report) Director Andrew D. Lipman sold 2,000 shares of the firm's stock in a transaction dated Thursday, April 25th. The shares were sold at an average price of $12.34, for a total value of $24,680.00. Following the transaction, the director now directly owns 25,225 shares in the company, valued at $311,276.50. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.

Nu Skin Enterprises Stock Down 1.8 %

Shares of NUS stock traded down $0.23 during midday trading on Thursday, reaching $12.25. 470,032 shares of the stock were exchanged, compared to its average volume of 753,528. The firm has a market cap of $605.15 million, a PE ratio of 69.23 and a beta of 1.11. The company has a current ratio of 2.13, a quick ratio of 1.28 and a debt-to-equity ratio of 0.58. The company's 50 day moving average is $12.80 and its two-hundred day moving average is $16.38. Nu Skin Enterprises, Inc. has a 1 year low of $11.84 and a 1 year high of $40.68.

Nu Skin Enterprises (NYSE:NUS - Get Free Report) last announced its quarterly earnings data on Wednesday, February 14th. The company reported $0.37 EPS for the quarter, beating the consensus estimate of $0.29 by $0.08. The business had revenue of $488.64 million during the quarter, compared to analyst estimates of $479.35 million. Nu Skin Enterprises had a return on equity of 10.73% and a net margin of 0.44%. On average, equities research analysts predict that Nu Skin Enterprises, Inc. will post 1.13 EPS for the current year.

Nu Skin Enterprises Cuts Dividend

The business also recently declared a quarterly dividend, which was paid on Wednesday, March 6th. Stockholders of record on Monday, February 26th were given a $0.06 dividend. The ex-dividend date was Friday, February 23rd. This represents a $0.24 dividend on an annualized basis and a dividend yield of 1.96%. Nu Skin Enterprises's dividend payout ratio is currently 133.34%.

Wall Street Analysts Forecast Growth

Several analysts have weighed in on the company. DA Davidson lowered their price objective on Nu Skin Enterprises from $29.00 to $21.00 and set a "neutral" rating for the company in a research report on Friday, January 5th. StockNews.com lowered shares of Nu Skin Enterprises from a "buy" rating to a "hold" rating in a report on Saturday, February 24th. Four analysts have rated the stock with a hold rating, According to data from MarketBeat, Nu Skin Enterprises has a consensus rating of "Hold" and a consensus target price of $23.67.

Institutional Trading of Nu Skin Enterprises

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Tudor Investment Corp Et Al increased its holdings in shares of Nu Skin Enterprises by 218.5% during the third quarter. Tudor Investment Corp Et Al now owns 127,750 shares of the company's stock valued at $2,710,000 after acquiring an additional 87,645 shares in the last quarter. Advisors Asset Management Inc. bought a new stake in Nu Skin Enterprises during the 3rd quarter valued at about $1,124,000. Nordea Investment Management AB raised its holdings in Nu Skin Enterprises by 71.4% in the third quarter. Nordea Investment Management AB now owns 237,920 shares of the company's stock worth $5,070,000 after buying an additional 99,138 shares during the last quarter. Caxton Associates LP bought a new position in shares of Nu Skin Enterprises in the third quarter worth approximately $995,000. Finally, Charles Schwab Investment Management Inc. grew its holdings in shares of Nu Skin Enterprises by 13.1% during the third quarter. Charles Schwab Investment Management Inc. now owns 984,504 shares of the company's stock valued at $20,881,000 after buying an additional 113,956 shares during the last quarter. Hedge funds and other institutional investors own 82.84% of the company's stock.

About Nu Skin Enterprises

Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.